🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations Kath 🎉 Well deserved! We are excited you are part of the Peter Mac CoE in Cellular Immunotherapy team committed to developing innovative #celltherapies. #WomeninScience

Jane Oliaro and colleagues Peter Mac Research Peter Mac CoE in Cellular Immunotherapy find through a #CRISPR screen that HOIP, the catalytic subunit of #LUBAC, confers #tumor cells protection from #apoptosis and tumor #immunity, which could thus be a target for #immunotherapy. ➡️➡️ embopress.org/doi/full/10.15…

Peter Mac's CoE CIT is excited to announce our new partnership with CellVec "This partnership with CellVec will underpin and enable a pipeline of high-potential research focused on developing the next generation of immunotherapies" - CoECIT director, Prof Simon Harrison

Scientists: Support for an overhaul in the distribution of NHMRC funding - Sign the Petition! chng.it/NdcWqYbm via @ChangeAUS

For everything you wanted to know about TNF and immunotherapy. Congrats 🎉 to Andrew freeman on this insightful review. Peter Mac Research WEHI (Walter and Eliza Hall Institute) #immunotherapy #TNF authors.elsevier.com/a/1e1dM5Eb0RmL…

Can we expand the potential of existing cancer therapies through strategic drug schedules & combinations? Read our perspective on harnessing the immunotherapeutic activity of CDK4/6 inhibitors for combo therapies nature.com/articles/s4169… Peter Mac Research npj Journals #precisiononcology

A must read Tale from Emily J Lelliott highlighting the importance of finding time to smell the "roses" along the way while dealing with the various pressures of being an academic! Check out the great figure! Peter Mac Research Peter Mac Cancer Centre Jane Oliaro Read here 👉 petermac.org/research/doing…

Cell Therapies was proud to have 12 of our team at the @biomelb Network 2022 Connecting Women Lunch providing an opportunity to reconnect and celebrate the achievements of women in the biotechnology, medical technology and pharmaceutical sectors in Victoria! #biomelbwomen

Carina Biotech and Cell Therapies Pty Ltd are partnering to deliver Carina's breakthrough CAR-T therapy clinical trial to patients, delivering on the promise of Australian sovereign research and manufacturing capabilities. celltherapies.com/carina-biotech… carinabiotech.com/carina-biotech…

Jane Oliaro is the very worthy recipient of a 3-year grant from The Leukemia & Lymphoma Society Leukaemia Foundation Snowdome Foundation to investigate how to make CAR T-cell therapy more effective in #myeloma & #lymphoma Peter Mac Cancer Centre Thank you for the funding support 🙏

Congrats 🎉 to the talented Emily J Lelliott on this beautifully crafted paper👇 in collab with Amy Brennan #dreamteam and Alan Baxter ♛ James Cook Uni #Nkg7 limits CD8+ T cell driven inflammation Peter Mac Research Peter Mac Postdoc Society (PMPS)

We're partnering with US-based Penn Medicine to advance development of new #cellulartherapies – including CAR T-cell therapy - and expand clinical trial access for Australian and American cancer patients petermac.org/news/global-ca…

Research is critical to achieving advancements in the treatment of blood cancer and we are proud to fund and support such innovative projects. Congratulations to all the researchers from @QIMRBerghofer & Peter Mac Cancer Centre and thanks for your important work.

Tonight, the blood cancer community will Light the Night 💙 Remember to share every special moment on social media and use the hashtag #LightTheNightAU ✨

Honoured to have been interviewed by BioCommunicationsAsn about the process behind our latest CAR-T production. If you'd like to find out about how it was created and what inspires me, take a look! bca.org/Post-Post-Deta… SciArt Initiative Peter Mac Research Peter Mac Cancer Centre Peter Mac Postdoc Society (PMPS)

Congratulations Emily!! 🎉 Winner of the Premiers Award for Basic Science AND Premiers Excellence Award. An amazing achievement, and recognition of your hard work and commitment to improve the lives of cancer patients Peter Mac Cancer Centre Peter Mac Research

"We are curing #cancers that less than 10 years ago we didn’t anticipate curing,” Professor Miles Prince. CAR T-cell, a form of #immunotherapy could #cure 80% of cancers within a generation. Calls for it to be available for #myeloma. bit.ly/3IEXvzq

In the CARTITUDE-4 trial, patients with lenalidomide-refractory multiple myeloma who received ciltacabtagene autoleucel (cilta-cel) had significantly longer progression-free survival than those who received standard therapy. View full results: nej.md/3MKxpfq #ASCO23

And the winner is… From the initial LCAR-B38M (NCT03090659), a dual epitope-binding CAR T directed against 2 BCMA epitopes, 1st presented at #ASH18 by colleagues from Xi’an Jiaotong Univ. (ShaanXi, China), to CARTITUDE-4 in the ⁦NEJM⁩, a superb journey made of success!

A momentous day as we open the Cell and Gene Therapy Manufacturing Facility at Peter Mac - Australia’s only biomedical manufacturing site where CAR T-cells and other “living” #cancer therapies can be made at commercial scale. Read more: petermac.org/about-us/news-…